Terms: = Gastric cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
40 results:
1. Case report: A case of advanced gastric cancer with multiple skin metastases, with significant relief from immunotherapy.
Hao W; Chang R; Liu J; Wang Y; Ren M; Xin K; Liu B; Xie J; Yang Y
Front Immunol; 2024; 15():1356350. PubMed ID: 38500887
[TBL] [Abstract] [Full Text] [Related]
2. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
Wang X; Liu X; Dai H; Jia J
BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
[TBL] [Abstract] [Full Text] [Related]
3. Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment.
Shaopeng Z; Yang Z; Yuan F; Chen H; Zhengjun Q
Cancer Med; 2024 Jan; 13(2):e6959. PubMed ID: 38349050
[TBL] [Abstract] [Full Text] [Related]
4. Identification of CERS5 as a molecular biomarker in pan-cancer through multiple omics integrative analysis.
Wang S; Yang J; Huang W; Yu Z; Mao Y; Feng Y; Chen J
Cell Signal; 2024 Apr; 116():111054. PubMed ID: 38244710
[TBL] [Abstract] [Full Text] [Related]
5. Redox probe-free electrochemical immunosensor utilizing electropolymerized melamine on reduced graphene oxide for the point-of-care diagnosis of gastric cancer.
Kanagavalli P; Eissa S
Talanta; 2024 Apr; 270():125549. PubMed ID: 38157735
[TBL] [Abstract] [Full Text] [Related]
6. Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and gastric cancer.
Désilets A; Elkhoury R; Gebai A; Tehfe M
Curr Oncol; 2023 Oct; 30(10):9304-9316. PubMed ID: 37887572
[TBL] [Abstract] [Full Text] [Related]
7. Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic gastric cancer by Liquid Biopsy.
Jung SH; Lee CK; Kwon WS; Yun S; Jung M; Kim HS; Chung HC; Chung YJ; Rha SY
Yonsei Med J; 2023 Sep; 64(9):531-540. PubMed ID: 37634629
[TBL] [Abstract] [Full Text] [Related]
8. Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review.
Yuan-Di Wang ; Yuan S; Wen C; Ji Z; Xiang B; Wang B; Zhang Z
Immunotherapy; 2023 Oct; 15(14):1117-1123. PubMed ID: 37431609
[TBL] [Abstract] [Full Text] [Related]
9. Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive gastric/ Gastroesophageal Adenocarcinoma.
Catenacci DV; Kang YK; Uronis HE; Lee KW; Ng MC; Enzinger PC; Park SH; Gold PJ; Lacy J; Hochster HS; Oh SC; Kim YH; Marrone KA; Kelly RJ; Juergens RA; Kim JG; Alcindor T; Sym SJ; Song EK; Chee CE; Chao Y; Kim S; Oh DY; Yen J; Odegaard JI; Lagow E; Li D; Sun J; Kaminker P; Moore PA; Rosales MK; Park H
Oncology (Williston Park); 2023 Apr; 37(4):176-183. PubMed ID: 37104758
[TBL] [Abstract] [Full Text] [Related]
10. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract] [Full Text] [Related]
11. Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia.
Venkatasamy A; Guerin E; Reichardt W; Devignot V; Chenard MP; Miguet L; Romain B; Jung AC; Gross I; Gaiddon C; Mellitzer G
Gastric Cancer; 2023 Mar; 26(2):220-233. PubMed ID: 36536236
[TBL] [Abstract] [Full Text] [Related]
12. Immunotherapy-Associated Hypophysitis under Anti-pd1: Two Case Reports.
Shen X; Yang M; Xu H; Zhou H; Wang L; Ma J
Endocr Metab Immune Disord Drug Targets; 2023; 23(7):996-1004. PubMed ID: 36503448
[TBL] [Abstract] [Full Text] [Related]
13. Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.
Jiang J; Ding Y; Lu J; Chen Y; Chen Y; Zhao W; Chen W; Kong M; Li C; Teng X; Zhou Q; Xu N; Zhou D; Zhou Z; Wang H; Teng L
Int J Biol Sci; 2022; 18(14):5554-5574. PubMed ID: 36147475
[TBL] [Abstract] [Full Text] [Related]
14. Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.
Yang G
Medicine (Baltimore); 2022 Aug; 101(34):e30311. PubMed ID: 36042639
[TBL] [Abstract] [Full Text] [Related]
15. A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma.
Wu X; Jian A; Tang H; Liu W; Liu F; Liu S; Wu H
Front Cell Infect Microbiol; 2022; 12():880636. PubMed ID: 35619651
[TBL] [Abstract] [Full Text] [Related]
16. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing.
Jiang H; Yu D; Yang P; Guo R; Kong M; Gao Y; Yu X; Lu X; Fan X
Clin Transl Med; 2022 Feb; 12(2):e730. PubMed ID: 35184420
[TBL] [Abstract] [Full Text] [Related]
17. Measurement of soluble pd-1 and soluble PD-L1 as well as PD-L1 and pd-1 from perioperative patients with gastric carcinoma.
Wei H; Wu F; Mao Y; Zhang Y; Leng G; Wang J; Zhang W; Wang T
Jpn J Clin Oncol; 2022 Apr; 52(4):331-345. PubMed ID: 35106596
[TBL] [Abstract] [Full Text] [Related]
18. A PD-L1 Negative Advanced gastric cancer Patient With a Long Response to pd-1 Blockade After Failure of Systematic Treatment: A Case Report.
Zhang F; Zhang J; Zhao L; Zhai M; Zhang T; Yu D
Front Immunol; 2021; 12():759250. PubMed ID: 34950137
[TBL] [Abstract] [Full Text] [Related]
19. Partial response of metastatic cardia neuroendocrine carcinoma with the combined therapy involving pd-1 blockade after failed multi-line chemotherapies: a case report and literature review.
Yang Y; Xu H; Zhang L; Bai L; Zhu H; Li Q
Anticancer Drugs; 2022 Feb; 33(2):214-219. PubMed ID: 34620744
[TBL] [Abstract] [Full Text] [Related]
20. PD-L1
Li Q; Zhou ZW; Lu J; Luo H; Wang SN; Peng Y; Deng MS; Song GB; Wang JM; Wei X; Wang D; Westover KD; Xu CX
Mol Ther; 2022 Feb; 30(2):621-631. PubMed ID: 34547468
[TBL] [Abstract] [Full Text] [Related]
[Next]
